This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's What Key Metrics Tell Us About Varonis (VRNS) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Varonis (VRNS) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Varonis Systems (VRNS) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Varonis (VRNS) delivered earnings and revenue surprises of +200.00% and +2.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Compared to Estimates, Varonis (VRNS) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Varonis (VRNS) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Varonis Systems (VRNS) Reports Break-Even Earnings for Q1
by Zacks Equity Research
Varonis (VRNS) delivered earnings and revenue surprises of 100% and 2.41%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Varonis Systems (VRNS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Varonis (VRNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Check Point Software (CHKP) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Check Point (CHKP) delivered earnings and revenue surprises of 0.91% and 0.22%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Zscaler (ZS): Can Its 3.1% Jump Turn into More Strength?
by Zacks Equity Research
Zscaler (ZS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Pre-Q4 Earnings: Should PATH Stock be in Your Portfolio?
by Shuvra Shankar Dey
UiPath's Q4 earnings drop tomorrow. Revenue growth is expected to be driven by subscription services, but the earnings forecast shows a dip.
The Zacks Analyst Blog Salesforce, Qualcomm, Verint, Varonis and S&P Global
by Zacks Equity Research
Salesforce, Qualcomm, Verint, Varonis and S&P Global are included in this Analyst Blog.
5 Big Data Providers to Buy on Lucrative Short-Term Upside Potential
by Nalak Das
Five Big Data stocks have strong revenue and earnings growth potential for 2025. These are: CRM, QCOM, VRNT, VRNS, SPGI.
How Much Upside is Left in Varonis (VRNS)? Wall Street Analysts Think 25.21%
by Zacks Equity Research
The consensus price target hints at a 25.2% upside potential for Varonis (VRNS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Varonis (VRNS) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Varonis (VRNS) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Varonis Systems (VRNS) Q4 Earnings Top Estimates
by Zacks Equity Research
Varonis (VRNS) delivered earnings and revenue surprises of 28.57% and 4.01%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Varonis (VRNS) Is a Great 'Buy the Bottom' Stock Now
by Zacks Equity Research
Varonis (VRNS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Varonis (VRNS) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Varonis (VRNS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Industry Outlook Highlights Qualys and Varonis Systems
by Zacks Equity Research
Qualys and Varonis Systems are part of the Zacks Industry Outlook article.
2 Stocks to Bet on From a Flourishing Security Industry
by Anirudha Bhagat
The Zacks Security industry participants, QLYS and VRNS, gain from an increase in data breaches, prompting companies to seek comprehensive IT security solutions.
Should You Buy, Sell, or Hold UiPath Stock Before Q3 Earnings?
by Shuvra Shankar Dey
PATH Q3 earnings drop tomorrow. Revenue growth is expected to be driven by subscription services, but the earnings forecast shows a dip.
Buy 5 Big Data Providers to Enhance Your Portfolio Returns in 2025
by Nalak Das
Five big data stocks have strong revenue and earnings growth potential for 2025. These are: DDOG, VRNS, PLTR, PRO, HUBS.
What Makes Varonis (VRNS) a New Buy Stock
by Zacks Equity Research
Varonis (VRNS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Compared to Estimates, Varonis (VRNS) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Varonis (VRNS) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Varonis Systems (VRNS) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Varonis (VRNS) delivered earnings and revenue surprises of 42.86% and 4.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
UiPath's Stock Price Decreases 49% YTD: How Should Investors Play?
by Arghyadeep Bose
Given the recent plummet in PATH's share price, we evaluate its current position to determine whether investors should buy, hold or sell the stock.
Zacks Industry Outlook Highlights Varonis and Qualys
by Zacks Equity Research
Varonis and Qualys have been highlighted in this Industry Outlook article.
2 Top-Ranked Stocks to Buy From the Prospering Security Industry
by Anirudha Bhagat
The Zacks Security industry participants like VRNS and QLYS benefit from the current hybrid working trend and the digital transformation wave.